<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37176025</PMID><DateCompleted><Year>2023</Year><Month>05</Month><Day>15</Day></DateCompleted><DateRevised><Year>2023</Year><Month>05</Month><Day>15</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1422-0067</ISSN><JournalIssue CitedMedium="Internet"><Volume>24</Volume><Issue>9</Issue><PubDate><Year>2023</Year><Month>May</Month><Day>05</Day></PubDate></JournalIssue><Title>International journal of molecular sciences</Title><ISOAbbreviation>Int J Mol Sci</ISOAbbreviation></Journal><ArticleTitle>Mechanisms Limiting Renal Tissue Protection and Repair in Glomerulonephritis.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">8318</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/ijms24098318</ELocationID><Abstract><AbstractText>Glomerulonephritis are renal disorders resulting from different pathogenic mechanisms (i.e., autoimmunity, complement, inflammatory activation, etc.). Clarifying details of the pathogenic cascade is basic to limit the progression from starting inflammation to degenerative stages. The balance between tissue injury, activation of protective systems and renal tissue repair determines the final outcome. Induction of an oxidative stress is part of glomerular inflammation and activation of protective antioxidant systems has a crucial role in reducing tissue effects. The generation of highly reactive oxygen species can be evaluated in vivo by tracing the inner-layer content of phosphatidyl ethanolamine and phosphatidyl serine in cell membranes. Albumin is the major antioxidant in serum and the level of oxidized albumin is another indirect sign of oxidative stress. Studies performed in Gn, specifically in FSGS, showed a high degree of oxidation in most contexts. High levels of circulating anti-SOD2 antibodies, limiting the detoxyfing activity of SOD2, have been detected in autoimmune Gn(lupus nephritis and membranous nephropathy) in association with persistence of proteinuria and worsening of renal function. In renal transplant, high levels of circulating anti-Glutathione S-transferase antibodies have been correlated with chronic antibody rejection and progressive loss of renal function. Annexins, mainly ANXA1 and ANXA2, play a general anti-inflammatory effect by inhibiting neutrophil functions. Cytosolic ANXA1 is decreased in apoptotic neutrophils of patients with glomerular polyangitis in association with delayed apoptosis that is considered the mechanism for polyangitis. High circulating levels of anti-ANXA1 and anti-ANXA2 antibodies characterize lupus nephritis implying a reduced anti-inflammatory effect. High circulating levels of antibodies targeting Macrophages (anti-FMNL1) have been detected in Gn in association with proteinuria. They potentially modify the intra-glomerular presence of protective macrophages (M2a, M2c) thus acting on the composition of renal infiltrate and on tissue repair.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Angeletti</LastName><ForeName>Andrea</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-6121-5326</Identifier><AffiliationInfo><Affiliation>Nephrology, Dialysis and Transplantation Unit, IRCCS, Istituto GianninaGaslini, 16147 Genova, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bruschi</LastName><ForeName>Maurizio</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Nephrology, Dialysis and Transplantation Unit, IRCCS, Istituto GianninaGaslini, 16147 Genova, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Experimental Medicine (DIMES), University of Genoa, 16126 Genoa, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kajana</LastName><ForeName>Xuliana</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Nephrology, Dialysis and Transplantation Unit, IRCCS, Istituto GianninaGaslini, 16147 Genova, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Spinelli</LastName><ForeName>Sonia</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0001-9847-4308</Identifier><AffiliationInfo><Affiliation>Nephrology, Dialysis and Transplantation Unit, IRCCS, Istituto GianninaGaslini, 16147 Genova, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Verrina</LastName><ForeName>Enrico</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Nephrology, Dialysis and Transplantation Unit, IRCCS, Istituto GianninaGaslini, 16147 Genova, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lugani</LastName><ForeName>Francesca</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Nephrology, Dialysis and Transplantation Unit, IRCCS, Istituto GianninaGaslini, 16147 Genova, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Caridi</LastName><ForeName>Gialuca</ForeName><Initials>G</Initials><Identifier Source="ORCID">0000-0001-6700-3001</Identifier><AffiliationInfo><Affiliation>Nephrology, Dialysis and Transplantation Unit, IRCCS, Istituto GianninaGaslini, 16147 Genova, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Murtas</LastName><ForeName>Corrado</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Nephrology and Dialysis Unit, Ospedale Belcolle, 01100 Viterbo, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Candiano</LastName><ForeName>Giovanni</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Nephrology, Dialysis and Transplantation Unit, IRCCS, Istituto GianninaGaslini, 16147 Genova, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Prunotto</LastName><ForeName>Marco</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-0203-0129</Identifier><AffiliationInfo><Affiliation>Institute of Pharmaceutical Sciences of Western Switzerland, School of Pharmaceutical Sciences, University of Geneva, 1205 Geneva, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ghiggeri</LastName><ForeName>Gian Marco</ForeName><Initials>GM</Initials><AffiliationInfo><Affiliation>Nephrology, Dialysis and Transplantation Unit, IRCCS, Istituto GianninaGaslini, 16147 Genova, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>05</Month><Day>05</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Int J Mol Sci</MedlineTA><NlmUniqueID>101092791</NlmUniqueID><ISSNLinking>1422-0067</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000975">Antioxidants</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000893">Anti-Inflammatory Agents</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008181" MajorTopicYN="Y">Lupus Nephritis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000975" MajorTopicYN="N">Antioxidants</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005921" MajorTopicYN="Y">Glomerulonephritis</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007249" MajorTopicYN="N">Inflammation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011507" MajorTopicYN="N">Proteinuria</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000893" MajorTopicYN="N">Anti-Inflammatory Agents</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Annexin family</Keyword><Keyword MajorTopicYN="N">glomerulonephritis</Keyword><Keyword MajorTopicYN="N">macrophages</Keyword><Keyword MajorTopicYN="N">oxidative systems</Keyword><Keyword MajorTopicYN="N">superoxide dismutase</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>3</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>4</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>5</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>5</Month><Day>15</Day><Hour>11</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>5</Month><Day>13</Day><Hour>15</Hour><Minute>12</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>5</Month><Day>13</Day><Hour>1</Hour><Minute>30</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37176025</ArticleId><ArticleId IdType="pmc">PMC10179029</ArticleId><ArticleId IdType="doi">10.3390/ijms24098318</ArticleId><ArticleId IdType="pii">ijms24098318</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Bruschi M., Petretto A., Vaglio A., Santucci L., Candiano G., Ghiggeri G.M. Annexin A1 and Autoimmunity: From Basic Science to Clinical Applications. Int. J. Mol. Sci. 2018;19:1348. doi: 10.3390/ijms19051348.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms19051348</ArticleId><ArticleId IdType="pmc">PMC5983684</ArticleId><ArticleId IdType="pubmed">29751523</ArticleId></ArticleIdList></Reference><Reference><Citation>Puthumana J., Thiessen-Philbrook H., Xu L., Coca S.G., Garg A.X., Himmelfarb J., Bhatraju P.K., Ikizler T.A., Siew E.D., Ware L.B., et al. Biomarkers of inflammation and repair in kidney disease progression. J. Clin. Investig. 2021;131 doi: 10.1172/JCI139927.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI139927</ArticleId><ArticleId IdType="pmc">PMC7843225</ArticleId><ArticleId IdType="pubmed">33290282</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghiggeri G.M., Seitz-Polski B., Justino J., Zaghrini C., Payr&#xe9; C., Brglez V., Dolla G., Sinico A., Scolari F., Vaglio A., et al. Multi-Autoantibody Signature and Clinical Outcome in Membranous Nephropathy. Clin. J. Am. Soc. Nephrol. 2020;15:1762&#x2013;1776. doi: 10.2215/CJN.02500220.</Citation><ArticleIdList><ArticleId IdType="doi">10.2215/CJN.02500220</ArticleId><ArticleId IdType="pmc">PMC7769033</ArticleId><ArticleId IdType="pubmed">33257410</ArticleId></ArticleIdList></Reference><Reference><Citation>Bruschi M., Sinico R.A., Moroni G., Pratesi F., Migliorini P., Galetti M., Murtas C., Tincani A., Madaio M., Radice A., et al. Glomerular autoimmune multicomponents of human lupus nephritis in vivo: Alpha-enolase and annexin AI. J. Am. Soc. Nephrol. 2014;25:2483&#x2013;2498. doi: 10.1681/ASN.2013090987.</Citation><ArticleIdList><ArticleId IdType="doi">10.1681/ASN.2013090987</ArticleId><ArticleId IdType="pmc">PMC4214525</ArticleId><ArticleId IdType="pubmed">24790181</ArticleId></ArticleIdList></Reference><Reference><Citation>Bruschi M., Cavalli A., Moll S., Candiano G., Scapozza L., Patel J.J., Tan J.C., Lo K.C., Angeletti A., Ghiggeri G.M., et al. Discovery of anti-Formin-like 1 protein (FMNL1) antibodies in membranous nephropathy and other glomerular diseases. Sci. Rep. 2022;12:13659. doi: 10.1038/s41598-022-17696-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-022-17696-w</ArticleId><ArticleId IdType="pmc">PMC9372176</ArticleId><ArticleId IdType="pubmed">35953506</ArticleId></ArticleIdList></Reference><Reference><Citation>Ginevri F., Ghiggeri G.M., Candiano G., Oleggini R., Bertelli R., Piccardo M.T., Perfumo F., Gusmano R. Peroxidative damage of the erythrocyte membrane in children with nephrotic syndrome. Pediatr. Nephrol. 1989;3:25&#x2013;32. doi: 10.1007/BF00859620.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF00859620</ArticleId><ArticleId IdType="pubmed">2484656</ArticleId></ArticleIdList></Reference><Reference><Citation>Musante L., Candiano G., Petretto A., Bruschi M., Dimasi N., Caridi G., Pavone B., Del Boccio P., Galliano M. Active focal segmental glomerulosclerosis is associated with massive oxidation of plasma albumin. J. Am. Soc. Nephrol. 2007;18:799&#x2013;810. doi: 10.1681/ASN.2006090965.</Citation><ArticleIdList><ArticleId IdType="doi">10.1681/ASN.2006090965</ArticleId><ArticleId IdType="pubmed">17287427</ArticleId></ArticleIdList></Reference><Reference><Citation>Bona N., Pezzarini E., Balbi B., Daniele S.M., Rossi M.F., Monje A.L., Basiglio C., Pelusa H.F., Arriaga S.M.M. Oxidative stress, inflammation and disease activity biomarkers in lupus nephropathy. Lupus. 2020;29:311&#x2013;323. doi: 10.1177/0961203320904784.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0961203320904784</ArticleId><ArticleId IdType="pubmed">32063098</ArticleId></ArticleIdList></Reference><Reference><Citation>Apeland T., Ushakova A., Mansoor M.A., Furriol J., Jonsson G., Marti H.-P. Association of redox and inflammation-related biomarkers with prognosis in IgA nephropathy: A prospective observational study. Free. Radic. Biol. Med. 2022;188:62&#x2013;70. doi: 10.1016/j.freeradbiomed.2022.06.224.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.freeradbiomed.2022.06.224</ArticleId><ArticleId IdType="pubmed">35716825</ArticleId></ArticleIdList></Reference><Reference><Citation>Bruschi M., Candiano G., Santucci L., Ghiggeri G.M. Oxidized albumin. The long way of a protein of uncertain function. Biochim. Biophys. Acta (BBA)&#x2014;Gen. Subj. 2013;1830:5473&#x2013;5479. doi: 10.1016/j.bbagen.2013.04.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbagen.2013.04.017</ArticleId><ArticleId IdType="pubmed">23618696</ArticleId></ArticleIdList></Reference><Reference><Citation>Russell T.M., Richardson D.R. The good Samaritan glutathione-S-transferase P1: An evolving relationship in nitric oxide metabolism mediat-ed by the direct interactions between multiple effector molecules. Redox Biol. 2023;59:102568. doi: 10.1016/j.redox.2022.102568.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.redox.2022.102568</ArticleId><ArticleId IdType="pmc">PMC9800640</ArticleId><ArticleId IdType="pubmed">36563536</ArticleId></ArticleIdList></Reference><Reference><Citation>Che M., Wang R., Li X., Wang H.-Y., Zheng X.S. Expanding roles of superoxide dismutases in cell regulation and cancer. Drug. Discov. Today. 2016;21:143&#x2013;149. doi: 10.1016/j.drudis.2015.10.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.drudis.2015.10.001</ArticleId><ArticleId IdType="pmc">PMC4724522</ArticleId><ArticleId IdType="pubmed">26475962</ArticleId></ArticleIdList></Reference><Reference><Citation>Buelli S., Perico L., Galbusera M., Abbate M., Morigi M., Novelli R., Gagliardini E., Tentori C., Rottoli D., Sabadini E., et al. Mitochondrial-dependent Autoimmunity in Membranous Nephropathy of IgG4-related Disease. Ebiomedicine. 2015;2:456&#x2013;466. doi: 10.1016/j.ebiom.2015.03.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2015.03.003</ArticleId><ArticleId IdType="pmc">PMC4485911</ArticleId><ArticleId IdType="pubmed">26137589</ArticleId></ArticleIdList></Reference><Reference><Citation>Tomas N.M., Hoxha E., Reinicke A.T., Fester L., Helmchen U., Gerth J., Bachmann F., Budde K., Koch-Nolte F., Zahner G., et al. Autoantibodies against thrombospondin type 1 domain&#x2013;containing 7A induce membranous nephropathy. J. Clin. Investig. 2016;126:2519&#x2013;2532. doi: 10.1172/JCI85265.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI85265</ArticleId><ArticleId IdType="pmc">PMC4922694</ArticleId><ArticleId IdType="pubmed">27214550</ArticleId></ArticleIdList></Reference><Reference><Citation>Prunotto M., Carnevali M.L., Candiano G., Murtas C., Bruschi M., Corradini E., Trivelli A., Magnasco A., Petretto A., Santucci L., et al. Autoimmunity in Membranous Nephropathy Targets Aldose Reductase and SOD2. J. Am. Soc. Nephrol. 2010;21:507&#x2013;519. doi: 10.1681/ASN.2008121259.</Citation><ArticleIdList><ArticleId IdType="doi">10.1681/ASN.2008121259</ArticleId><ArticleId IdType="pmc">PMC2831859</ArticleId><ArticleId IdType="pubmed">20150532</ArticleId></ArticleIdList></Reference><Reference><Citation>Angeletti A., Bruschi M., Moroni G., Sinico R.A., Franceschini F., Fredi M., Vaglio A., Cavagna L., Petretto A., Pratesi F., et al. Second Wave Antibodies in Autoimmune Renal Diseases: The Case of Lupus Nephritis. J. Am. Soc. Nephrol. 2021;32:3020&#x2013;3023. doi: 10.1681/ASN.2021050659.</Citation><ArticleIdList><ArticleId IdType="doi">10.1681/ASN.2021050659</ArticleId><ArticleId IdType="pmc">PMC8638388</ArticleId><ArticleId IdType="pubmed">34599042</ArticleId></ArticleIdList></Reference><Reference><Citation>Beck L.H., Bonegio R.G., Lambeau G., Beck D.M., Powell D.W., Cummins T.D., Klein J.B., Salant D.J. M-Type Phospholipase A2 Receptor as Target Antigen in Idiopathic Membranous Nephropathy. N. Engl. J. Med. 2009;361:11&#x2013;21. doi: 10.1056/NEJMoa0810457.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa0810457</ArticleId><ArticleId IdType="pmc">PMC2762083</ArticleId><ArticleId IdType="pubmed">19571279</ArticleId></ArticleIdList></Reference><Reference><Citation>Aguilera I., Alvarez-Marquez A., Gentil M.A., Fernandez-Alonso J., Fijo J., Saez C., Wichmann I., Nu&#xf1;ez-Roldan A. Anti-glutathione S-transferase T1 antibody-mediated rejection in C4d-positive renal allo-graft recipients. Nephrol. Dial. Transplant. 2008;23:2393&#x2013;2398. doi: 10.1093/ndt/gfm955.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ndt/gfm955</ArticleId><ArticleId IdType="pubmed">18308775</ArticleId></ArticleIdList></Reference><Reference><Citation>Comoli P., Cioni M., Ray B., Tagliamacco A., Innocente A., Caridi G., Bruschi M., Hariharan J., Fontana I., Trivelli A., et al. Anti-glutathione S-transferase theta 1 antibodies correlate with graft loss in non-sensitized pediatric kidney recipients. Front. Med. 2022;9:3559. doi: 10.3389/fmed.2022.1035400.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2022.1035400</ArticleId><ArticleId IdType="pmc">PMC9748144</ArticleId><ArticleId IdType="pubmed">36530923</ArticleId></ArticleIdList></Reference><Reference><Citation>Creutz C., Pazoles C., Pollard H. Identification and purification of an adrenal medullary protein (synexin) that causes calcium-dependent aggregation of isolated chromaffin granules. J. Biol. Chem. 1978;253:2858&#x2013;2866. doi: 10.1016/S0021-9258(17)40901-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0021-9258(17)40901-X</ArticleId><ArticleId IdType="pubmed">632306</ArticleId></ArticleIdList></Reference><Reference><Citation>Markoff A., Gerke V. Expression and functions of annexins in the kidney. Am. J. Physiol. Physiol. 2005;289:F949&#x2013;F956. doi: 10.1152/ajprenal.00089.2005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajprenal.00089.2005</ArticleId><ArticleId IdType="pubmed">16210453</ArticleId></ArticleIdList></Reference><Reference><Citation>McKanna J.A., Chuncharunee A., Munger K.A., Breyer J.A., Cohen S., Harris R.C. Localization of p35 (annexin I, lipocortin I) in normal adult rat kidney and during recovery from ischemia. J. Cell. Physiol. 1992;153:467&#x2013;476. doi: 10.1002/jcp.1041530305.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jcp.1041530305</ArticleId><ArticleId IdType="pubmed">1447309</ArticleId></ArticleIdList></Reference><Reference><Citation>Perretti M., Gavins F.N.E. Annexin 1: An Endogenous Anti-Inflammatory Protein. Physiology. 2003;18:60&#x2013;64. doi: 10.1152/nips.01424.2002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/nips.01424.2002</ArticleId><ArticleId IdType="pubmed">12644621</ArticleId></ArticleIdList></Reference><Reference><Citation>Gerke V., Moss S.E. Annexins: From Structure to Function. Physiol. Rev. 2002;82:331&#x2013;371. doi: 10.1152/physrev.00030.2001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/physrev.00030.2001</ArticleId><ArticleId IdType="pubmed">11917092</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferlazzo V., D&#x2019;Agostino P., Milano S., Caruso R., Feo S., Cillari E., Parente L. Anti-inflammatory effects of annexin-1: Stimulation of IL-10 release and inhibition of nitric oxide synthesis. Int. Immunopharmacol. 2003;3:1363&#x2013;1369. doi: 10.1016/S1567-5769(03)00133-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1567-5769(03)00133-4</ArticleId><ArticleId IdType="pubmed">12946433</ArticleId></ArticleIdList></Reference><Reference><Citation>Sugimoto M.A., Vago J.P., Teixeira M.M., Sousa L.P. Annexin A1 and the Resolution of Inflammation: Modulation of Neutrophil Recruitment, Apoptosis, and Clearance. J. Immunol. Res. 2016;2016:8239258. doi: 10.1155/2016/8239258.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2016/8239258</ArticleId><ArticleId IdType="pmc">PMC4738713</ArticleId><ArticleId IdType="pubmed">26885535</ArticleId></ArticleIdList></Reference><Reference><Citation>Lim L.H.K., Solito E., Russo-Marie F., Flower R.J., Perretti M. Promoting detachment of neutrophils adherent to murine postcapillary venules to control inflammation: Effect of lipocortin 1. Proc. Natl. Acad. Sci. USA. 1998;95:14535&#x2013;14539. doi: 10.1073/pnas.95.24.14535.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.95.24.14535</ArticleId><ArticleId IdType="pmc">PMC24408</ArticleId><ArticleId IdType="pubmed">9826735</ArticleId></ArticleIdList></Reference><Reference><Citation>Zouki C., Ouellet S., Filep J.G. The anti-inflammatory peptides, antiflammins, regulate the expression of adhesion molecules on human leu-kocytes and prevent neutrophil adhesion to endothelial cells. FASEB J. 2000;14:572&#x2013;580. doi: 10.1096/fasebj.14.3.572.</Citation><ArticleIdList><ArticleId IdType="doi">10.1096/fasebj.14.3.572</ArticleId><ArticleId IdType="pubmed">10698973</ArticleId></ArticleIdList></Reference><Reference><Citation>Scannell M., Flanagan M.B., Destefani A., Wynne K.J., Cagney G., Godson C., Maderna P. Annexin-1 and Peptide Derivatives Are Released by Apoptotic Cells and Stimulate Phagocytosis of Apoptotic Neutrophils by Macrophages. J. Immunol. 2007;178:4595&#x2013;4605. doi: 10.4049/jimmunol.178.7.4595.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.178.7.4595</ArticleId><ArticleId IdType="pubmed">17372018</ArticleId></ArticleIdList></Reference><Reference><Citation>Ricci E., Ronchetti S., Pericolini E., Gabrielli E., Cari L., Gentili M., Roselletti E., Migliorati G., Vecchiarelli A., Riccardi C. Role of the glucocorticoid-induced leucine zipper gene in dexamethasone-induced inhibition of mouse neutrophil migration via control of annexin A1 expression. FASEB J. 2017;31:3054&#x2013;3065. doi: 10.1096/fj.201601315R.</Citation><ArticleIdList><ArticleId IdType="doi">10.1096/fj.201601315R</ArticleId><ArticleId IdType="pubmed">28373208</ArticleId></ArticleIdList></Reference><Reference><Citation>Perretti M., D&#x2019;Acquisto F. Annexin A1 and glucocorticoids as effectors of the resolution of inflammation. Nat. Rev. Immunol. 2009;9:62&#x2013;70. doi: 10.1038/nri2470.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nri2470</ArticleId><ArticleId IdType="pubmed">19104500</ArticleId></ArticleIdList></Reference><Reference><Citation>Chatterjee B.E., Yona S., Rosignoli G., Young R.E., Nourshargh S., Flower R.J., Perretti M. Annexin 1-deficient neutrophils exhibit enhanced transmigration in vivo and increased respon-siveness in vitro. J. Leukoc. Biol. 2005;78:639&#x2013;646. doi: 10.1189/jlb.0405206.</Citation><ArticleIdList><ArticleId IdType="doi">10.1189/jlb.0405206</ArticleId><ArticleId IdType="pubmed">16000391</ArticleId></ArticleIdList></Reference><Reference><Citation>Frey O., Petrow P.K., Gajda M., Siegmund K., Huehn J., Scheffold A., Hamann A., Radbruch A., Br&#xe4;uer R. The role of regulatory T cells in antigen-induced arthritis: Aggravation of arthritis after depletion and amelioration after transfer of CD4+CD25+ T cells. Thromb. Haemost. 2005;7:R291&#x2013;R301. doi: 10.1186/ar1484.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/ar1484</ArticleId><ArticleId IdType="pmc">PMC1065322</ArticleId><ArticleId IdType="pubmed">15743476</ArticleId></ArticleIdList></Reference><Reference><Citation>Mozaffari M.S. Therapeutic Potential of Annexin A1 Modulation in Kidney and Cardiovascular Disorders. Cells. 2021;10:3420. doi: 10.3390/cells10123420.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells10123420</ArticleId><ArticleId IdType="pmc">PMC8700139</ArticleId><ArticleId IdType="pubmed">34943928</ArticleId></ArticleIdList></Reference><Reference><Citation>Everts-Graber J., Martin K.R., Thieblemont N., Mocek J., Roccabianca A., Chafey P., Le Gall M., Tacnet-Delorme P., Reutelingsperger C.P., Naccache J.-M., et al. Proteomic analysis of neutrophils in ANCA-associated vasculitis reveals a dysregulation in proteinase 3-associated proteins such as annexin-A1 involved in apoptotic cell clearance. Kidney Int. 2019;96:397&#x2013;408. doi: 10.1016/j.kint.2019.02.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.kint.2019.02.017</ArticleId><ArticleId IdType="pubmed">31142442</ArticleId></ArticleIdList></Reference><Reference><Citation>Hajjar K.A., Hamel N.M. Identification and characterization of human endothelial cell membrane binding sites for tissue plasminogen acti-vator and urokinase. J. Biol. Chem. 1990;265:2908&#x2013;2916. doi: 10.1016/S0021-9258(19)39887-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0021-9258(19)39887-4</ArticleId><ArticleId IdType="pubmed">2154465</ArticleId></ArticleIdList></Reference><Reference><Citation>Luo M., Flood E.C., Almeida D., Yan L., Berlin D.A., Heerdt P.M., Hajjar K.A. Annexin A2 supports pulmonary microvascular integrity by linking vascular endothelial cadherin and protein tyrosine phosphatases. J. Exp. Med. 2017;214:2535&#x2013;2545. doi: 10.1084/jem.20160652.</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20160652</ArticleId><ArticleId IdType="pmc">PMC5584111</ArticleId><ArticleId IdType="pubmed">28694388</ArticleId></ArticleIdList></Reference><Reference><Citation>Laumonnier Y., Syrovets T., Burysek L., Simmet T. Identification of the annexin A2 heterotetramer as a receptor for the plasmin-induced signaling in human peripheral monocytes. Blood. 2006;107:3342&#x2013;3349. doi: 10.1182/blood-2005-07-2840.</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood-2005-07-2840</ArticleId><ArticleId IdType="pubmed">16373665</ArticleId></ArticleIdList></Reference><Reference><Citation>Brownstein C., Deora A.B., Jacovina A.T., Weintraub R., Gertler M., Khan K.M.F., Falcone D.J., Hajjar K.A. Annexin II mediates plasminogen-dependent matrix invasion by human monocytes: Enhanced expression by macrophages. Blood. 2004;103:317&#x2013;324. doi: 10.1182/blood-2003-04-1304.</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood-2003-04-1304</ArticleId><ArticleId IdType="pubmed">14504107</ArticleId></ArticleIdList></Reference><Reference><Citation>He S., Li X., Li R., Fang L., Sun L., Wang Y., Wu M. Annexin A2 Modulates ROS and Impacts Inflammatory Response via IL-17 Signaling in Polymicrobial Sepsis Mice. PLOS Pathog. 2016;12:e1005743. doi: 10.1371/journal.ppat.1005743.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1005743</ArticleId><ArticleId IdType="pmc">PMC4936746</ArticleId><ArticleId IdType="pubmed">27389701</ArticleId></ArticleIdList></Reference><Reference><Citation>Ling Q., Jacovina A.T., Deora A., Febbraio M., Simantov R., Silverstein R.L., Hempstead B., Mark W.H., Hajjar K.A. Annexin II regulates fibrin homeostasis and neoangiogenesis in vivo. J. Clin. Investig. 2004;113:38&#x2013;48. doi: 10.1172/JCI19684.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI19684</ArticleId><ArticleId IdType="pmc">PMC300771</ArticleId><ArticleId IdType="pubmed">14702107</ArticleId></ArticleIdList></Reference><Reference><Citation>Morand E.F., Hall P., Hutchinson P., Yang Y.H. Regulation of Annexin I in Rheumatoid Synovial Cells by Glucocorticoids and Interleukin-1. Mediat. Inflamm. 2006;2006:73835. doi: 10.1155/MI/2006/73835.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/MI/2006/73835</ArticleId><ArticleId IdType="pmc">PMC1592590</ArticleId><ArticleId IdType="pubmed">16883066</ArticleId></ArticleIdList></Reference><Reference><Citation>Bruschi M., Moroni G., Sinico R.A., Franceschini F., Fredi M., Vaglio A., Cavagna L., Petretto A., Pratesi F., Migliorini P., et al. Neutrophil Extracellular Traps in the Autoimmunity Context. Front. Med. 2021;8:614829. doi: 10.3389/fmed.2021.614829.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2021.614829</ArticleId><ArticleId IdType="pmc">PMC8019736</ArticleId><ArticleId IdType="pubmed">33829021</ArticleId></ArticleIdList></Reference><Reference><Citation>Goulding N.J., Jefferiss C.M., Pan L., Rigby W.F., Guyre P.M. Specific binding of lipocortin-1 (annexin I) to monocytes and neutrophils is de-creased in rheumatoid arthritis. Arthritis Rheum. 1992;35:1395&#x2013;1397. doi: 10.1002/art.1780351126.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.1780351126</ArticleId><ArticleId IdType="pubmed">1445462</ArticleId></ArticleIdList></Reference><Reference><Citation>Kretz C.C., Norpo M., Abeler-D&#xf6;rner L., Linke B., Haust M., Edler L., Krammer P.H., Kuhn A. Anti-annexin 1 antibodies: A new diagnostic marker in the serum of patients with discoid lupus erythematosus. Exp. Dermatol. 2010;19:919&#x2013;921. doi: 10.1111/j.1600-0625.2010.01145.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1600-0625.2010.01145.x</ArticleId><ArticleId IdType="pubmed">20701627</ArticleId></ArticleIdList></Reference><Reference><Citation>Bonanni A., Vaglio A., Bruschi M., Sinico R.A., Cavagna L., Moroni G., Franceschini F., Allegri L., Pratesi F., Migliorini P., et al. Multi-antibody composition in lupus nephritis: Isotype and antigen specificity make the difference. Autoimmun. Rev. 2015;14:692&#x2013;702. doi: 10.1016/j.autrev.2015.04.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.autrev.2015.04.004</ArticleId><ArticleId IdType="pubmed">25888464</ArticleId></ArticleIdList></Reference><Reference><Citation>Bruschi M., Moroni G., Sinico R.A., Franceschini F., Fredi M., Vaglio A., Cavagna L., Petretto A., Pratesi F., Migliorini P., et al. Serum IgG2 antibody multicomposition in systemic lupus erythematosus and lupus nephritis (Part 1): Cross-sectional analysis. Rheumatology. 2020;60:3176&#x2013;3188. doi: 10.1093/rheumatology/keaa767.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/rheumatology/keaa767</ArticleId><ArticleId IdType="pmc">PMC8487649</ArticleId><ArticleId IdType="pubmed">33374003</ArticleId></ArticleIdList></Reference><Reference><Citation>Bruschi M., Angeletti A., Kajana X., Moroni G., Sinico R.A., Fredi M., Vaglio A., Cavagna L., Pratesi F., Migliorini P., et al. Evidence for charge-based mimicry in anti dsDNA antibody generation. J. Autoimmun. 2022;132:102900. doi: 10.1016/j.jaut.2022.102900.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaut.2022.102900</ArticleId><ArticleId IdType="pubmed">36087539</ArticleId></ArticleIdList></Reference><Reference><Citation>Cesarman-Maus G.C., R&#xed;os-Luna N.P., Deora A.B., Huang B., Villa R., Cravioto M.D.C., Alarc&#xf3;n-Segovia D., S&#xe1;nchez-Guerrero J., Hajjar K.A. Autoantibodies against the fibrinolytic receptor, annexin 2, in antiphospholipid syndrome. Blood. 2006;107:4375&#x2013;4382. doi: 10.1182/blood-2005-07-2636.</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood-2005-07-2636</ArticleId><ArticleId IdType="pmc">PMC1895790</ArticleId><ArticleId IdType="pubmed">16493010</ArticleId></ArticleIdList></Reference><Reference><Citation>Ao W., Zheng H., Chen X.W., Shen Y., Yang C.D. Anti-annexin II antibody is associated with thrombosis and/or pregnancy morbidity in an-tiphospholipid syndrome and systemic lupus erythematosus with thrombosis. Rheumatol. Int. 2011;31:865&#x2013;869. doi: 10.1007/s00296-010-1379-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00296-010-1379-4</ArticleId><ArticleId IdType="pubmed">20229030</ArticleId></ArticleIdList></Reference><Reference><Citation>Yung S., Cheung K.F., Zhang Q., Chan T.M. Anti-dsDNA antibodies bind to mesangial annexin II in lupus nephritis. J. Am. Soc. Nephrol. 2010;21:1912&#x2013;1927. doi: 10.1681/ASN.2009080805.</Citation><ArticleIdList><ArticleId IdType="doi">10.1681/ASN.2009080805</ArticleId><ArticleId IdType="pmc">PMC3014006</ArticleId><ArticleId IdType="pubmed">20847146</ArticleId></ArticleIdList></Reference><Reference><Citation>Ye Q., Zhang Y., Zhuang J., Bi Y., Xu H., Shen Q., Liu J., Fu H., Wang J., Feng C., et al. The important roles and molecular mechanisms of annexin A2 autoantibody in children with nephrotic syndrome. Ann. Transl. Med. 2021;9:1452. doi: 10.21037/atm-21-3988.</Citation><ArticleIdList><ArticleId IdType="doi">10.21037/atm-21-3988</ArticleId><ArticleId IdType="pmc">PMC8506724</ArticleId><ArticleId IdType="pubmed">34734004</ArticleId></ArticleIdList></Reference><Reference><Citation>Mosser D.M., Edwards J.P. Exploring the full spectrum of macrophage activation. Nat. Rev. Immunol. 2008;8:958&#x2013;969. doi: 10.1038/nri2448.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nri2448</ArticleId><ArticleId IdType="pmc">PMC2724991</ArticleId><ArticleId IdType="pubmed">19029990</ArticleId></ArticleIdList></Reference><Reference><Citation>Serhan C.N., Savill J. Resolution of inflammation: The beginning programs the end. Nat. Immunol. 2005;6:1191&#x2013;1197. doi: 10.1038/ni1276.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ni1276</ArticleId><ArticleId IdType="pubmed">16369558</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferrario F., Castiglione A., Colasanti G., di Belgioioso G.B., Bertoli S., D&#x2019;Amico G., Nava S. The detection of monocytes in human glomerulonephritis. Kidney Int. 1985;28:513&#x2013;519. doi: 10.1038/ki.1985.158.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ki.1985.158</ArticleId><ArticleId IdType="pubmed">4068484</ArticleId></ArticleIdList></Reference><Reference><Citation>Nolasco F.E., Cameron J.S., Hartley B., Coelho A., Hildreth G., Reuben R. Intraglomerular T cells and monocytes in nephritis: Study with mono-clonal antibodies. Kidney Int. 1987;31:1160&#x2013;1166. doi: 10.1038/ki.1987.123.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ki.1987.123</ArticleId><ArticleId IdType="pubmed">3496476</ArticleId></ArticleIdList></Reference><Reference><Citation>Bolton W.K., Innes D.J., Jr., Sturgill B.C., Kaiser D.L. T-cells and macrophages in rapidly progressive glomerulonephritis: Clinicopathologic correla-tions. Kidney Int. 1987;32:869&#x2013;876. doi: 10.1038/ki.1987.288.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ki.1987.288</ArticleId><ArticleId IdType="pubmed">3501499</ArticleId></ArticleIdList></Reference><Reference><Citation>Moll S., Angeletti A., Scapozza L., Cavalli A., Ghiggeri G.M., Prunotto M. Glomerular Macrophages in Human Auto- and Allo-Immune Nephritis. Cells. 2021;10:603. doi: 10.3390/cells10030603.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells10030603</ArticleId><ArticleId IdType="pmc">PMC7998925</ArticleId><ArticleId IdType="pubmed">33803230</ArticleId></ArticleIdList></Reference><Reference><Citation>Bohle A., Wehrmann M., Bogenschutz O., Batz C., Vog W., Schmitt H., M&#xfc;ller C.A., M&#xfc;ller G.A. The long-term prognosis of the primary glomerulonephritides. A morphological and clinical analysis of 1747 cases. Pathol. Res. Pract. 1992;188:908&#x2013;924. doi: 10.1016/S0344-0338(11)80252-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0344-0338(11)80252-9</ArticleId><ArticleId IdType="pubmed">1448382</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodr&#xed;guez-Iturbe B., Pons H., Herrera-Acosta J., Johnson R.J. Role of immunocompetent cells in nonimmune renal diseases. Kidney Int. 2001;59:1626&#x2013;1640. doi: 10.1046/j.1523-1755.2001.0590051626.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1523-1755.2001.0590051626.x</ArticleId><ArticleId IdType="pubmed">11318933</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y., Harris D.C. Macrophages in Renal Disease. J. Am. Soc. Nephrol. 2011;22:21&#x2013;27. doi: 10.1681/ASN.2010030269.</Citation><ArticleIdList><ArticleId IdType="doi">10.1681/ASN.2010030269</ArticleId><ArticleId IdType="pubmed">21209251</ArticleId></ArticleIdList></Reference><Reference><Citation>Cailhier J.F., Partolina M., Vuthoori S., Wu S., Ko K., Watson S., Savill J., Hughes J., Lang R.A. Conditional macrophage ablation demonstrates that resident macrophages initiate acute peri-toneal inflammation. J. Immunol. 2005;174:2336&#x2013;2342. doi: 10.4049/jimmunol.174.4.2336.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.174.4.2336</ArticleId><ArticleId IdType="pubmed">15699170</ArticleId></ArticleIdList></Reference><Reference><Citation>Jung S., Unutmaz D., Wong P., Sano G.-I., Santos K.D.L., Sparwasser T., Wu S., Vuthoori S., Ko K., Zavala F., et al. In Vivo Depletion of CD11c+ Dendritic Cells Abrogates Priming of CD8+ T Cells by Exogenous Cell-Associated Antigens. Immunity. 2002;17:211&#x2013;220. doi: 10.1016/S1074-7613(02)00365-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1074-7613(02)00365-5</ArticleId><ArticleId IdType="pmc">PMC3689299</ArticleId><ArticleId IdType="pubmed">12196292</ArticleId></ArticleIdList></Reference><Reference><Citation>Alexander J.J., Chaves L.D., Chang A., Jacob A., Ritchie M., Quigg R.J. CD11b is protective in complement-mediated immune complex glomeru-lonephritis. Kidney Int. 2015;87:930&#x2013;939. doi: 10.1038/ki.2014.373.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ki.2014.373</ArticleId><ArticleId IdType="pmc">PMC4424815</ArticleId><ArticleId IdType="pubmed">25565310</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y., Zheng G., Lee V., Ouyang L., Chang D., Mahajan D., Coombs J., Alexander S., Harris D. Ex vivo programmed macrophages ameliorate experimental chronic inflammatory renal disease. Kidney Int. 2007;72:290&#x2013;299. doi: 10.1038/sj.ki.5002275.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/sj.ki.5002275</ArticleId><ArticleId IdType="pubmed">17440493</ArticleId></ArticleIdList></Reference><Reference><Citation>Cao Q., Wang Y., Zheng D., Sun Y., Wang Y., Lee V.W.S., Zheng G., Tan T.K., Ince J., Alexander S., et al. IL-10/TGF-beta-modified macrophages induce regulatory T cells and protect against adriamycin nephrosis. J. Am. Soc. Nephrol. 2010;21:933&#x2013;942. doi: 10.1681/ASN.2009060592.</Citation><ArticleIdList><ArticleId IdType="doi">10.1681/ASN.2009060592</ArticleId><ArticleId IdType="pmc">PMC2900959</ArticleId><ArticleId IdType="pubmed">20299353</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu J., Cao Q., Zheng D., Sun Y., Wang C., Yu X., Wang Y., Lee V.W., Zheng G., Tan T.K., et al. Discrete functions of M 2a and M 2c macrophage subsets determine their relative efficacy in treating chronic kidney disease. Kidney Int. 2013;84:745&#x2013;755. doi: 10.1038/ki.2013.135.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ki.2013.135</ArticleId><ArticleId IdType="pubmed">23636175</ArticleId></ArticleIdList></Reference><Reference><Citation>Bruschi M., Petretto A., Santucci L., Vaglio A., Pratesi F., Migliorini P., Bertelli R., Lavarello C., Bartolucci M., Candiano G., et al. Neutrophil Extracellular Traps protein composition is specific for patients with Lupus nephritis and includes methyl-oxidized alphaenolase (methionine sulfoxide 93) Sci. Rep. 2019;9:7934. doi: 10.1038/s41598-019-44379-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-019-44379-w</ArticleId><ArticleId IdType="pmc">PMC6538718</ArticleId><ArticleId IdType="pubmed">31138830</ArticleId></ArticleIdList></Reference><Reference><Citation>Bello-Gamboa A., Velasco M., Moreno S., Herranz G., Ilie R., Huetos S., D&#xe1;vila S., S&#xe1;nchez A., De La Serna J.B., Calvo V., et al. Actin reorganization at the centrosomal area and the immune synapse regulates polarized secretory traffic of multivesicular bodies in T lymphocytes. J. Extracell. Vesicles. 2020;9:1759926. doi: 10.1080/20013078.2020.1759926.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/20013078.2020.1759926</ArticleId><ArticleId IdType="pmc">PMC7480611</ArticleId><ArticleId IdType="pubmed">32939232</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumari S., Colin-York H., Irvine D.J., Fritzsche M. Not All T Cell Synapses Are Built the Same Way. Trends Immunol. 2019;40:977&#x2013;980. doi: 10.1016/j.it.2019.09.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.it.2019.09.009</ArticleId><ArticleId IdType="pmc">PMC7322532</ArticleId><ArticleId IdType="pubmed">31645298</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>